:: Volume 20, Issue 6 (Bimonthly 2017) ::
Feyz 2017, 20(6): 532-538 Back to browse issues page
Prevalence of aminoglycoside resistance and ant(2”)-I gene in Pseudomonas aeruginosa isolated from burn wound specimens in Yazd
Mohadeseh Zarei-Yazdeli , Gilda Eslami , Hajar Mirsafaei , Hengameh Zandi , Marziyeh Shokohi Far , Masoumeh Kiani
Research Center for Food Hygiene and Safety, Shahid Sadoughi University of Medical Sciences Yazd, I. R. Iran. , hengameh_zandi@yahoo.com
Abstract:   (4374 Views)

Background: Pseudomonas aeruginosa is one of the most important causative agents among the hospital acquired infections, especially in ICU and burn units. Enzymatic inactivation of aminoglycosides by aminoglycoside-modifying enzymes is the main mechanism of resistance to these antibiotics in Pseudomonas aeruginosa. The aim of this study was to study the aminoglycoside resistance and ant (2”)-I in Pseudomonas aeruginosa isolated from burn specimens in Yazd, Iran.

Materials and Methods: This cross-sectional study was carried out on Pseudomonas aeruginosa isolates (no=73) during July 2014 to April 2015. All burn wound samples were initially identified by the standard biochemical methods and their aminoglycoside resistance was studied using the disc diffusion method according to CLSI recommendations. PCR method was carried out for the detection of aminoglycoside resistance using ant (2”)-I gene specific primers.

Results: Forty (54.8%) out of 73 cases were male (mean age 29±2.25 years). The resistance rates as determined by the disk diffusion method were: Kanamycin (89%), Gentamicin (67.1%), Tobramycin (58.9%) and Amikacin (60.3%). The PCR results showed that 63 (86.3%) of the isolates were harbored the ant (2”)-I gene.

Conclusion: The results of this study show that resistance to aminoglycosides is high in pseudomonas aeruginosa isolated from burn wounds. The presence of gene ant (2”)-I was widely reported. In addition, there was a significant relationship between this gene and resistance to aminoglycosides.  
Keywords: Pseudomonas aeruginosa, aminoglycoside resistance, ant (2”)-I gene, Burn wound
Full-Text [PDF 236 kb]   (1934 Downloads)    
Type of Study: Research | Subject: General
Received: 2017/01/2 | Revised: 2017/07/24 | Accepted: 2017/01/2 | Published: 2017/01/2
References
1. Goldberg JB. Pseudomonas: global bacteria. Trends Microbiol 2000; 8(2): 55-7.
2. Murray PR. Medical bacteriology. 6th ed. Translated by: Bahador A. Tehran, Khosravi & Dibaj Publisher; 2009. p. 269-77. [in Persian]
3. Navon-Venezia S, Ben-Ami R, Carmeli Y. update on pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 2005; 18(4): 306-13.
4. Rastegar Lari AR, Alaghebandan R, Akhlaghi L. Burn wound infections and antimicrobial resistancein Tehran, Iran: An increasing problem.Ann Burns Fire Disasters 2005; 18(2): 68-73.
5. Poole K. Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2011; 2: 65.
6. Vakulenko SB, Mobashery S. Versatility Of aminoglycosides and prospects for their future. Clin Microbiol Rev 2003; 16(3): 430-50.
7. Murray BE. Diversity among multidrug resistant Enterococci. Emerg Infect Dis 2002; 4(1): 37-47
8. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34(5): 634-40.
9. Mandell G, Bennett J, Dolin R. Mandell,Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone; 2010. p. 307-36.
10. Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2005; 49(2): 479–87.
11. Aghazadeh M, Rezaee MA, Nahaei MR, Mahdian R, Pajand O, Saffari F, et al. Dissemination of aminoglycoside-modifying enzymes and 16S rRNA methylases among Acinetobacter baumannii and Pseudomonas aeruginosa isolates. Microb Drug Resist 2013; 19(4): 282-8.
12. Kim JY, Park YJ, Kwon HJ, Han K, Kang MW, Woo GJ. Occurrence and mechanisms of amikacin resistance and its association with b-lactamases in Pseudomonas aeruginosa: a Korean nationwide study. J Antimicrob Chemother 2008; 62(3): 479-83.
13. Over U, Gur D, Unal S, Miller GH. The changing nature of aminoglyco- side resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin Microbiol Infect 2001; 7(9): 470-8.
14. Wu Y, Li H, Li J, Huang ZH. Detection of Pseudomonas aeruginosa carried a new array of gene cassettes within class 1 integron isolated from a teaching hospital in Nanjing, China. J Microbiol 2008; 46(6): 687-91.
15. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial suscep¬tibility testing; twenty first informational supple¬ment. CLSI document M100-S21. CLSI 2011 Wayne, PA.
16. Sambrook J, Russell D. Molecular cloning: a laboratory manual. 3rd ed. New York: Cold Spring Harbor Press; 2001.
17. Sekiguchi JI, Asagi T, Miyoshi-Akiyama T, Kasai A, Mizuguchi Y, Araake M, et al. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol 2007; 45(3): 979–89.
18. Hosseini Jazani N, Omrani MD, Yekta Z, Nejadrahim R, Afshar Yavari Sh, Zartoshti M. Plasmid Profile of Pseudomonas aeruginosa and its Relation with Antibiotic Resistance in Hospital Isolates. J Kerman Univ Med Sci 2008; 15(1): 9-17. [in Persian]
19. Akhi MT, Hasanzadeh AR. Bacteria involved in burn infections, sensitivity patterns. J Tabriz Univ Med Sci 2006; 27(2): 7-11. [in Persian]
20. Mamani M, Derakhshanfar A, Niayesh A, Hashemi SH, Yosefi Mashoof R, Zavar S.Frequency of Bacterial Burn Wounds Infection and Antimicrobial Resistance in Burn Center of Bessat Hospital of Hamedan. Iran J Surgery 2009; 17(1). [in Persian]
21. Owlia P, Bahador MA, Saderi H, Aminil H. Antibiotic resistance pattern of isolated Pseudomona aeruginosa stratins from isolated Pseudomona aeruginosa strains from infections of burned patients. J Med Council IRI 2007; 25(1): 26-33. [in Persian]
22. Kohanteb J, Dayaghi M, Motazedian M, Ali Ghayumi M. Comparison of biotyping and antibiotyping of Pseudomonas aeruginosa isolated from patients with burn wound infection and nosocomial pneumonia in Shiraz, Iran. Pak J BiolSci 2007; 10(11): 1817-22.
23. Franco MR, Caiaffa-Filho HH, Burattini MN, Rossi F. Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics 2010, 65(9): 825-9.
24. Poonsuk K, Tribuddharat C, Chuanchuen R. Aminoglycoside resistance mechanisms in Pseudomonas aeruginosa isolates from non-cystic fibrosis patients in Thailand. Can J Microbiol 2013; 59(1): 51-6.
25. Elmanama AA, Laham NA, Tayh GA. Antimicrobial susceptibility of bacterial isolates from burn units in Gaza. Burns 2013; 39(8): 1612-8.
26. Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, Andre C, et al. blactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). J Antimicrob Chemother 2008; 62(2): 316-23.
27. Bojary Nasrabadi MR, Hajia M. Multidrug-resistant. Pseudomonas aeruginosa strains in Tehran Reference Burn Hospital, Tehran, Iran. Afr J Microbiol Res 2012; 6(7): 1393-6.
28. Vaziri F, Najar Peerayeh SH, Behzadian Nejad Q, Farhadian A. The prevalence of aminoglycoside-modifying enzyme genes (aac (6)-I, aac (6)-II, ant (2)-I,aph (3)-VI) in Pseudomonas aeruginosa. Clinics (Sao Paulo) 2011; 66(9): 1519-22.
29. Taghizadeh B, Hasani A, Hasani A, Varshochi M, Dehghani L, Hajiazadeh M. Detection of Integron Genes Responsible for Antibiotic Resistance In Pseudomonas aeruginosa Isolated from Urinary Tract Infections of Patients Admitted to High Risk Wards of Hospitals of Tabriz. The 13th Iranian and the 2nd international Congress of microbiology. 2012.

XML   Persian Abstract   Print

Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 20, Issue 6 (Bimonthly 2017) Back to browse issues page